Animal Antibiotics and Antimicrobials Market: An Outlook to the Future Global Opportunities

The growth in this market is majorly attributed to factors such as growing animal population, rising animal healthcare expenditure, rising pet adoption, growing demand for animal-derived food products, rising awareness about zoonotic diseases, and implementation of regulations for preventing the spread of animal diseases.

The Animal Antibiotics and Antimicrobials Market witnessed significant growth during the last decade and is expected to grow at a CAGR of 4.6% between 2016 and 2021 to reach 4.73 Billion by 2021.

Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=25161353

The global animal antibiotics and antimicrobials market is segmented based on product, mode of delivery, animal type, and geography.

Based on product type, the market is segmented into tetracyclines, penicillins, sulfonamides, macrolides, aminoglycosides, cephalosporins, lincosamides, fluoroquinolones, and other antibiotics and antimicrobials.

Based on mode of delivery, the market is further categorized into premixes, oral powders, oral solutions, injections, and other modes of delivery. Based on animal type, the market is segmented into food-producing animals and companion animals. The food-producing animals segment is further segmented into cattle, pigs, sheep and goats, poultry, and other food-producing animals. Similarly, on the basis of geography, the animal antibiotics and antimicrobials market is segmented into North-America, Europe, Asia-Pacific, and Rest of the World.

In 2015, the tetracyclines segment accounted for the largest share of the global animal antibiotics and antimicrobials market. However, fluoroquinolones segment is expected to witness the highest growth over the next five years.

North America is the largest regional segment for animal antibiotics and antimicrobials market owing to the well-established animal healthcare market. The largest share of this regional segment is driven by increasing demand for animal-derived food products, rising animal healthcare expenditure, growing animal population, and rising awareness about zoonotic diseases.

Read More: - https://www.marketsandmarkets.com/PressReleases/animal-antimicrobials-antibiotics.asp

The market players, namely, Zoetis, Inc. (U.S.), Merck & Co., Inc. (U.S.), Bayer AG (Germany), Eli Lilly and Company (U.S.), and Virbac (France)